Utolsó frissítés :
19/11/2024
Antibiotikum   Nafcillin sodium  
Injekció
Az oldatok stabilitása A keverékek stabilitása Stabilitást befolyásoló tényezők Kompatibilitás Az alkalmazás módja Irodalom pdf
   Kémiai szerkezet   

Kereskedelmi név   Kereskedelmi név     

A kereskedelmi név meghatározó jelentőségű: a készítmények összetétele országonként, előállítóként eltérő lehet

Nafcillin Amerikai Egyesült Államok, Törökország
Unipen Kanada
Irodalom   Injekció   Irodalom : Nafcillin sodium  
Type publikáció
13 Napló Stiles ML, Allen LV.
Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium and tobramycin sulfate in polyvinyl chloride drug reservoirs.
Am J Health-Syst Pharm 1997 ; 54: 1068-1070.
129 Napló Smythe M, Malouf E.
Visual compatibility of insulin with secondary intravenous drugs in admixtures.
Am J Hosp Pharm 1991 ; 48: 125-126.
176 Napló Mantong ML, Marquardt ED.
Visual compatibility of midazolam hydrochloride with selected drugs during simulated Y-site injection.
Am J Health-Syst Pharm 1995 ; 52: 2567-2568.
198 Napló Gayed AA, Kheshary PR, Hinkle RL.
Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
Am J Health-Syst Pharm 1995 ; 52: 516-520.
278 Napló Hagan RL, Carr-Lopez S, Strickland JS.
Stability of nafcillin sodium in the presence of lidocaine hydrochloride.
Am J Health-Syst Pharm 1995 ; 52: 521-523.
300 Napló Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
301 Napló Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
317 Napló Kershaw BP, Monnier HL, Mason JH.
Visual compatibility of premixed theophylline or heparin with selected drugs for IV administration.
Am J Hosp Pharm 1993 ; 50: 1360-1362.
336 Napló Forman JK, Lachs JR, Souney PF.
Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection.
Am J Hosp Pharm 1987 ; 44: 1408-1409.
337 Napló Bashaw ED, Amantea MA, Minor JR, Galleli JF.
Visual compatibility of zidovudine with other drugs during simulated Y-site administration.
Am J Hosp Pharm 1988 ; 45: 2532-2533.
371 Napló Thompson DF, Stiles ML, Allen LV, Tu YH.
Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection.
Am J Hosp Pharm 1988 ; 45: 142-145.
384 Napló Colucci RD, Cobuzzi LE, Halpern NA.
Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection.
Am J Hosp Pharm 1988 ; 45: 630-632.
386 Napló Colucci RD, Cobuzzi LE, Halpern NA.
Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
Am J Hosp Pharm 1988 ; 45: 1357-1358.
397 Napló Fong PA, Ward J.
Visual compatibility of intravenous famotidine with selected drugs.
Am J Hosp Pharm 1989 ; 46: 125-126.
405 Napló Nieves-Cordero AL, Luciw HM, Souney PF.
Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1985 ; 42: 1108-1109.
406 Napló Smythe MA, Patel MA, Gasloli RA.
Visual compatibility of narcotic analgesics with selected intravenous admixtures.
Am J Hosp Pharm 1990 ; 47: 819-820.
433 Napló Riley CM, Lipford LC.
Interaction of aztreonam with nafcillin in intravenous admixtures.
Am J Hosp Pharm 1986 ; 43: 2221-2224.
496 Napló Lor E, Sheybani T, Takagi J.
Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
Am J Hosp Pharm 1991 ; 48: 744-746.
574 Napló Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ.
Stability of antibiotics frozen and stored in disposable hypodermic syringes.
Am J Hosp Pharm 1980 ; 37: 1087-1088.
575 Napló Holmes CJ, Ausman RK, Kundsin RB, Walter CW.
Effect of freezing and microwave thawing on the stability of six antibiotic admixtures in plastic bags.
Am J Hosp Pharm 1982 ; 39: 104-108.
630 Napló Das Gupta V, Stewart KR.
Stability of metronidazole and ten antibiotics when mixed with magnesium sulphate solutions.
J Clin Hosp Pharm 1985 ; 10: 67-72.
999 Napló Watson D.
Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution.
JPEN 1985 ; 9: 220-224.
1047 Napló Souney PF, Colucci RD, Mariani G, Campbell D.
Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1984 ; 41: 323-324.
1057 Napló Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1099 Napló Tucker R, Gentile JF.
Precipitation of verapamil in an intravenous line.
Ann Intern Med 1984 ; 101: 880.
1135 Napló Baltz JK, Kennedy P, Minor JR, Gallelli J.
Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
Am J Hosp Pharm 1990 ; 47: 2075-2077.
1315 Napló Halpern NA, Colucci RD, Alicea M, Greenstein R.
Visual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injection.
Int J Pharm Clin Pharmacol Ther Tox 1989 ; 27: 294-297.
1351 Napló Tucker R, Gentle JF.
Precipitation of verapamil with nafcillin.
Am J Hosp Pharm 1984 ; 41: 2588.
1366 Napló Jeglum EL, Winter E, Kotos M.
Nafcillin sodium incompatibility with acidic solutions.
Am J Hosp Pharm 1981 ; 38: 462,464.
1415 Napló Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
JPEN 1999 ; 23: 67-74.
1490 Napló Halpern NA, Colucci RD, Alicea M, Greenstein R.
The compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injection.
Int J Pharm Clin Pharmacol Ther Tox 1989 ; 27: 250-254.
1674 Napló Trissel LA, Gilbert DL, Martinez JF.
Concentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 1515-1522.
1705 Napló Zhang Y, Trissel LA.
Stability of ampicillin sodium, nafcillin sodium, and oxacillin sodium in autodose system bags.
Int J Pharm Compound 2002 ; 6: 226-229.
2005 Napló Chan V.
Influence of temperature and drug concentration on nafcillin precipitation.
Am J Health-Syst Pharm 2005 ; 62: 1347-1348.
2247 Napló Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
2352 Napló Ling J, Das Gupta V.
Stability of nafcillin sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Int J Pharm Compound 2000 ; 4, 6: 480-481.
3503 Laboratórium Fentanyl - Summary of product Characteristics
Hameln Pharmaceuticals 2012
3520 Laboratórium Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3529 Laboratórium Ciprofloxacin – Summary of Product Characteristics
Hospira 2013
3547 Laboratórium Aztréonam (Azactam®) - Résumé des caractéristiques du produit
Sanofi-Aventis France 2011
3549 Laboratórium Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3580 Laboratórium Cytarabine Accord - Résumé des caractéristiques du produit
Accord Healthcare France 2016
3643 Laboratórium Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3674 Laboratórium Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
4154 Laboratórium Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018

  Mentions Légales